Tamoxifen for Progressive Transitional Cell Carcinoma Following Previous Chemotherapy Treatment

Clinical trial NCT00710970 · COMPLETED

Trial details

NCT number: NCT00710970
Sponsor: Seth Lerner
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Urinary Bladder Neoplasms

Start date: 2007-01-01
Primary completion: 2011-12-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.